Article

Probiotic Mix has Benefits in Relapsing Ulcerative Colitis

Adding a high-potency probiotic mix may improve the clinical picture of patients with ulcerative colitis on immunosuppresive therapy.

This video features discussion of a study that found that the addition of a high-potency probiotic mixture to the treatment regimen of patients with relapsing mild-to-moderate ulcerative colitis on immunosuppressive therapy may “improve the clinical picture” and allow these patients to avoid a new course of steroids.

Click here to access this third-party resource.

Related Videos
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Safety Data on Dupilumab, Ensifentrine for COPD, with MeiLan Han, MD
© 2024 MJH Life Sciences

All rights reserved.